Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International (PM) maintains a dynamic presence in global markets through strategic initiatives and product evolution. This news hub provides investors and industry observers with essential updates about the company's financial performance, reduced-risk product developments, and regulatory engagements.
Access timely press releases and curated analysis covering PM's quarterly earnings, market expansion strategies, and innovations in smoke-free alternatives like heatsticks and oral nicotine products. Our repository simplifies tracking of critical milestones including acquisition announcements, sustainability efforts, and leadership changes impacting this tobacco industry leader.
All content undergoes rigorous verification to ensure accuracy and relevance for stakeholders monitoring PM's transition toward reduced-risk portfolios. Bookmark this page for streamlined access to operational updates and strategic disclosures from one of the world's largest publicly traded tobacco enterprises.
Philip Morris International (NYSE: PM) urged the FDA advisory committee on October 7, 2025 to recommend continued marketing of IQOS as a modified risk tobacco product (MRTP). The FDA previously found evidence supporting the reduced-exposure claim for IQOS. PMI submitted renewal requests covering two device versions and three HEETS variants and highlighted global usage figures: ~34 million legal-age IQOS consumers as of June 30, 2025 and 41 million smoke-free product users globally. PMI stated its smoke-free business accounted for 41% of H1 2025 net revenues and noted ongoing FDA reviews for IQOS ILUMA (pending ~two years).
Philip Morris International (NYSE: PM) has announced a $37 million investment in its Wilson, North Carolina manufacturing facility. The expansion will add a production line for TEREA, the consumables for the IQOS ILUMA heated tobacco system, pending FDA authorization.
The Wilson facility, which currently employs over 80 full-time staff, produces HEETS for IQOS 3.0, the only FDA-authorized modified risk tobacco product with reduced exposure claims. This investment is part of PMI's broader U.S. manufacturing expansion, which includes a $232 million investment in Owensboro, Kentucky, and a $600 million facility in Aurora, Colorado, collectively creating nearly 1,000 direct jobs.
The expansion reinforces PMI's commitment to advancing a smoke-free future by providing better alternatives to approximately 30 million legal-age consumers who smoke cigarettes in the U.S.
Philip Morris International (NYSE: PM) released findings from a new international survey showing overwhelming public support for smoke-free alternatives to cigarettes. The survey revealed that 78% of respondents believe adult smokers should have access to better alternatives to smoking, while 74% agree that encouraging switches to these products could improve public health.
Key findings highlight that 76% of respondents are concerned about decisions being made based on ideology rather than science. Currently, over 190 million smokers in more than 20 countries lack legal access to smoke-free alternatives, despite cigarettes remaining widely available. The survey also found that 82% of legal-age smokers in countries with bans on smoke-free products would like the opportunity to purchase them legally.
Philip Morris International (NYSE: PM) has announced an 8.9% increase in its regular quarterly dividend to an annualized rate of $5.88 per share. The new quarterly dividend of $1.47 per share will be payable on October 20, 2025, to shareholders of record as of October 3, 2025.
PMI has maintained a consistent track record of dividend increases since its public listing in 2008, achieving a total increase of 219.6% with a compound annual growth rate of 7.1%. The company's smoke-free products are now available in 97 markets, reaching over 41 million consumers, and accounting for 41% of PMI's first-half 2025 total net revenues.
The company has invested over $14 billion in developing smoke-free products since 2008, with FDA authorizations for its IQOS devices, Swedish Match's General snus, and ZYN nicotine pouches.
Philip Morris International (NYSE: PM) has released its 2025 Sustainability Materiality Report, outlining its sustainability strategy through 2030 and beyond. The report, following double materiality principles, identifies six strategic priorities organized into a new Sustainability Framework focusing on both product and operational impacts.
The Framework addresses product impact through social consumer initiatives and environmental circularity, while operational impact covers workforce development, value chain ethics, climate action, and nature protection. PMI's smoke-free products are now available in 97 markets, used by 41 million consumers, and account for 41% of first-half 2025 total net revenues. The company has invested over $14 billion since 2008 in developing and commercializing smoke-free alternatives.
Philip Morris International (NYSE: PM) reaffirmed its 2025 full-year forecast during the Barclays Global Consumer Staples Conference. The company expects reported diluted EPS of $7.24 to $7.37 and adjusted diluted EPS of $7.43 to $7.56, representing growth of 13% to 15% (11.5% to 13.5% excluding currency).
PMI reported strong Q3-to-date performance, highlighting accelerated ZYN growth to 32% in the first 8 weeks of Q3, robust IQOS momentum, and better-than-expected combustible volume recovery in Turkey and Egypt. The company's smoke-free products are now available in 97 markets, used by over 41 million consumers, and accounted for 41% of first-half 2025 total net revenues.
Since 2008, PMI has invested over $14 billion in smoke-free product development, aiming to completely end cigarette sales and expand into wellness and healthcare areas.
Philip Morris International (NYSE: PM) announced it will host a fireside chat session at the 2025 Barclays Global Consumer Staples Conference. CEO Jacek Olczak will lead the session on September 2, 2025, at 11:15 a.m. ET, with a live webcast available at pmi.com/2025barclays.
The company provided key business updates, highlighting that its smoke-free products are now available in 97 markets with approximately 41 million users globally. The smoke-free segment contributed 41% of PMI's first-half 2025 total net revenues. Since 2008, PMI has invested over $14 billion in developing and commercializing smoke-free products, demonstrating its commitment to a smoke-free future.
Philip Morris International (NYSE: PM) reported strong Q2 2025 results, with reported diluted EPS growing 26.6% to $1.95 and adjusted diluted EPS increasing 20.1% to $1.91. The company's smoke-free business now accounts for 41% of total net revenues, up 2.9 percentage points year-over-year.
Key highlights include IQOS exceeding $3 billion in quarterly net revenues, ZYN's U.S. offtake growth reaccelerating to 36% in June, and smoke-free product shipment volumes increasing by 11.8%. The company raised its full-year 2025 guidance, now projecting adjusted diluted EPS of $7.43-$7.56, representing 13-15% growth.
Total net revenues reached $10.1 billion, up 7.1% year-over-year, while operating income grew 7.8% to $3.7 billion. The company's smoke-free products are now available in 97 markets, with IQOS maintaining approximately 76% global heat-not-burn category share.
Philip Morris International (NYSE: PM) has announced it will host a live audio webcast to discuss its 2025 second-quarter and first-half results on Tuesday, July 22, 2025, at 9:00 a.m. ET. The results will be released at approximately 7:00 a.m. ET the same day.
The company's smoke-free products are now available in 95 markets with approximately 38.6 million adult users globally. The smoke-free segment represented 42% of PMI's Q1 2025 total net revenues. PMI has invested over $14 billion since 2008 in developing and commercializing smoke-free products, with FDA authorizations for IQOS devices, General snus, and ZYN nicotine pouches.
FAQ
What is the current stock price of Philip Morris (PM)?
What is the market cap of Philip Morris (PM)?
